Form 4 for SPRY ARS Pharmaceuticals, Inc.
Accepted 2024-10-17 00:00:00 ET · period of report 2024-10-16 · accession 0001415889-24-025370 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-10-17 | 2024-10-16 | SPRY | Scott Kathleen D. | CFO | S - Sale+OE | $16.00 | -12.5K | 4,949 | -72% | -$200.0K |
| D | 2024-10-17 | 2024-10-16 | SPRY | Scott Kathleen D. | CFO | M - OptEx | $1.50 | +12.5K | 17.4K | +253% | +$18.8K |
| D | 2024-10-17 | 2024-10-16 | SPRY | Scott Kathleen D. | CFO | M - OptEx | $0.00 | -12.5K | 802.3K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-16 | S | D | 12,500 | $16.00 | 4,949 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-16 | M | A | 12,500 | $1.50 | 17,449 | D | — | — | (F1) The Reporting Person inadvertently added the holdings of Scott 2008 Trust Dated 3/28/08 (the "Trust") as directly held on her Form 4 filed on August 20, 2024. As of the date of that Form 4, the Reporting Person owned 8,250 shares indirectly through the Trust. |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-10-16 | M | D | 12,500 | $0.00 | 802,330 | D | $1.50 · — to 2032-02-29 | 12,500 Common Stock | (F4) Immediately exercisable. |